Aviva (OTCMKTS:AVVIY) Hits New 12-Month High - Here's Why

Key Points

• Aviva PLC shares reached a new 52-week high of $18.88, closing at $18.60 with a trading volume of 10,030 shares.
• Analyst ratings indicate a mix, with Citigroup upgrading Aviva to a "hold" while Barclays downgraded it; currently, the stock holds a consensus rating of "Moderate Buy".
• Aviva provides a range of insurance and investment products across several regions, including the UK, Ireland, and Canada.

Shares of Aviva PLC (OTCMKTS:AVVIY - Get Free Report) reached a new 52-week high on Monday . The company traded as high as $18.88 and last traded at $18.60, with a volume of 10030 shares. The stock had previously closed at $18.57.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the company. Citigroup raised Aviva to a "hold" rating in a research report on Tuesday, July 15th. Barclays downgraded Aviva from a "strong-buy" rating to a "hold" rating in a report on Monday, June 16th. Two analysts have rated the stock with a Strong Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy".

Aviva Price Performance

The business's 50 day moving average price is $17.45 and its 200-day moving average price is $15.67. The company has a quick ratio of 1.86, a current ratio of 1.86 and a debt-to-equity ratio of 0.67.

Aviva Company Profile

Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.